This finding also provides support for the idea that excessive hepatic expression of the BCKDK, now understood to also play a role in regulation of the critical DNL enzyme ACLY (9), plays an important role in the development of NAFLD in human obesity. The gene discussed is BCKDK; the disease is obesity due to melanocortin 4 receptor deficiency.